These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 28184155)

  • 21. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity of physician-diagnosed COPD in relation to spirometric definitions of COPD in a general population aged 50-64 years - the SCAPIS pilot study.
    Torén K; Murgia N; Olin AC; Hedner J; Brandberg J; Rosengren A; Bergström G
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2269-2275. PubMed ID: 28831247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
    Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations.
    Cheng Y; Tu X; Pan L; Lu S; Xing M; Li L; Chen X
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2069-2074. PubMed ID: 28790809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease.
    Chun EM; Kim SW; Lim SY
    Int J Chron Obstruct Pulmon Dis; 2015; 10():955-60. PubMed ID: 26028968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An association between chronic obstructive pulmonary disease and abdominal aortic aneurysm beyond smoking: results from a case-control study.
    Meijer CA; Kokje VB; van Tongeren RB; Hamming JF; van Bockel JH; Möller GM; Lindeman JH
    Eur J Vasc Endovasc Surg; 2012 Aug; 44(2):153-7. PubMed ID: 22705161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ratio of FEV
    Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
    Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation.
    Kitaguchi Y; Yasuo M; Hanaoka M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():991-7. PubMed ID: 27274220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of gastrectomy in patients with spirometry-defined COPD and patients at risk of COPD: a case-control study.
    Saito H; Nomura K; Abe S; Motegi T; Ishii T; Hattori K; Kusunoki Y; Gemma A; Kida K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2311-8. PubMed ID: 26604730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
    Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
    Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
    Stockley RA; Edgar RG; Pillai A; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel CT-emphysema index/FEV
    Loh LC; Ong CK; Koo HJ; Lee SM; Lee JS; Oh YM; Seo JB; Lee SD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2543-2550. PubMed ID: 30174423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobe-based computed tomography assessment of airway diameter, airway or vessel number, and emphysema extent in relation to the clinical outcomes of COPD.
    Kurashima K; Takaku Y; Hoshi T; Kanauchi T; Nakamoto K; Takayanagi N; Yanagisawa T; Sugita Y; Kawabata Y
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1027-33. PubMed ID: 26082626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
    Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort.
    Tejwani V; Fawzy A; Putcha N; Castaldi PJ; Cho MH; Pratte KA; Bhatt SP; Lynch DA; Humphries SM; Kinney GL; D'Alessio FR; Hansel NN;
    Chest; 2021 Oct; 160(4):1245-1254. PubMed ID: 34029566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.